retatrutide gip glp-1 glucagon receptor agonist Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA The Effects of Dual GLP-1/GIP

Stool that becomes narrow (pencil-shaped or ribbon-like ) or shows significant shape/size changes

Dalton TP, Dieter MZ, Yang Y, Shertzer HG, Nebert DW: Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous

They are the hallmark of autoimmune thyroid disease, which is characterized by chronic inflammation in the thyroid gland

The pharmacist can have a key role in educating patients and providers about the importance of regular diabetes follow-up, home glucose monitoring, frequent HbA1c testing, and why multiple medications are needed